174 related articles for article (PubMed ID: 22389341)
1. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.
Baltussen R; Smith A
BMJ; 2012 Mar; 344():e615. PubMed ID: 22389341
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ortegón M; Lim S; Chisholm D; Mendis S
BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study.
Stanciole AE; Ortegón M; Chisholm D; Lauer JA
BMJ; 2012 Mar; 344():e608. PubMed ID: 22389338
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.
Chisholm D; Saxena S
BMJ; 2012 Mar; 344():e609. PubMed ID: 22389339
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study.
Chisholm D; Naci H; Hyder AA; Tran NT; Peden M
BMJ; 2012 Mar; 344():e612. PubMed ID: 22389340
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of selected interventions for hearing impairment in Africa and Asia: a mathematical modelling approach.
Baltussen R; Smith A
Int J Audiol; 2009 Mar; 48(3):144-58. PubMed ID: 19283586
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.
Adam T; Lim SS; Mehta S; Bhutta ZA; Fogstad H; Mathai M; Zupan J; Darmstadt GL
BMJ; 2005 Nov; 331(7525):1107. PubMed ID: 16282407
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of screening and correcting refractive errors in school children in Africa, Asia, America and Europe.
Baltussen R; Naus J; Limburg H
Health Policy; 2009 Feb; 89(2):201-15. PubMed ID: 18621429
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness analysis of strategies for tuberculosis control in developing countries.
Baltussen R; Floyd K; Dye C
BMJ; 2005 Dec; 331(7529):1364. PubMed ID: 16282379
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of malaria control in sub-Saharan Africa.
Goodman CA; Coleman PG; Mills AJ
Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
14. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis.
Bertram MY; Chisholm D; Watts R; Waqanivalu T; Prasad V; Varghese C
Int J Health Policy Manag; 2021 Nov; 10(11):724-733. PubMed ID: 34273918
[TBL] [Abstract][Full Text] [Related]
16. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Interventions to Improve Maternal, Newborn and Child Health Outcomes: A WHO-CHOICE Analysis for Eastern Sub-Saharan Africa and South-East Asia.
Stenberg K; Watts R; Bertram MY; Engesveen K; Maliqi B; Say L; Hutubessy R
Int J Health Policy Manag; 2021 Nov; 10(11):706-723. PubMed ID: 33904699
[TBL] [Abstract][Full Text] [Related]
18. GDP Matters: Cost Effectiveness of Cochlear Implantation and Deaf Education in Sub-Saharan Africa.
Emmett SD; Tucci DL; Smith M; Macharia IM; Ndegwa SN; Nakku D; Mukara KB; Ibekwe TS; Mulwafu W; Gong W; Francis HW; Saunders JE
Otol Neurotol; 2015 Sep; 36(8):1357-65. PubMed ID: 26244622
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
Kuznik A; Habib AG; Munube D; Lamorde M
BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
